Risk of Major Bleeding with Anti-Aggregation and/or Anticoagulation therapy in Inherited Factor XI Deficiency: Insights from Real-World Observations

Authors

Shanni Vaismann

Published

June 18, 2024

Abstract

Received: 07 April 2024 Accepted after revision: 15 June 2024 Accepted Manuscript online:18 June 2024

Supporters

Support the authors with ResearchCoin

Journal

Thrombosis and Haemostasis

Topics

Nutrition And Dietetics

DOI

10.1055/a-2347-4338

Risk of Major Bleeding with Anti-Aggregation and/or Anticoagulation therapy in Inherited Factor XI Deficiency: Insights from Real-World Observations

Authors

Shanni Vaismann

Published

June 18, 2024

Abstract

Received: 07 April 2024 Accepted after revision: 15 June 2024 Accepted Manuscript online:18 June 2024

Supporters

Support the authors with ResearchCoin

Journal

Thrombosis and Haemostasis

Topics

Nutrition And Dietetics

DOI

10.1055/a-2347-4338

Paper

Paper

Paper

Paper

Risk of Major Bleeding with Anti-Aggregation and/or Anticoagulation therapy in Inherited Factor XI Deficiency: Insights from Real-World Observations

Abstract

Supporters

Journal

Topics

DOI

Risk of Major Bleeding with Anti-Aggregation and/or Anticoagulation therapy in Inherited Factor XI Deficiency: Insights from Real-World Observations

Abstract

Supporters

Journal

Topics

DOI